Cargando…

Brain-targeted ex vivo lentiviral gene therapy: Implications for MPS and beyond

Detalles Bibliográficos
Autor principal:	Bradbury, Allison M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630102/ https://www.ncbi.nlm.nih.gov/pubmed/38027070 http://dx.doi.org/10.1016/j.omtm.2023.101137

Ejemplares similares

Toward lentiviral vectors for antiangiogenic ocular gene therapy
por: Askou, Anne Louise, et al.
Publicado: (2023)

Ex vivo gene transfer in the years to come
por: Pap, Thomas, et al.
Publicado: (2002)

Effective in vivo and ex vivo gene transfer to intestinal mucosa by VSV-G-pseudotyped lentiviral vectors
por: Matsumoto, Hiroshi, et al.
Publicado: (2010)

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
por: Aiuti, Alessandro, et al.
Publicado: (2017)

TSLP‐targeting therapy: Beyond allergy?
por: Ebina‐Shibuya, Risa, et al.
Publicado: (2023)

Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA
por: Ellison, Stuart M., et al.
Publicado: (2019)

Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering
por: Soldi, Monica, et al.
Publicado: (2020)

Driving DNA transposition by lentiviral protein transduction
por: Cai, Yujia, et al.
Publicado: (2014)

Highly efficient ex vivo lentiviral transduction of primary human pancreatic exocrine cells
por: Balak, Jeetindra R. A., et al.
Publicado: (2019)

Ex vivo manipulation of bone marrow cells to rescue uremia-induced dysfunction for autologous therapy
por: Grange, Cristina, et al.
Publicado: (2015)

Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant Ex Vivo Gene Therapy Settings
por: Petrillo, Carolina, et al.
Publicado: (2019)

Successful ex vivo expansion of mouse hematopoietic stem cells
por: Ema, Hideo
Publicado: (2019)

Pseudotyped Lentiviral Vectors for Retrograde Gene Delivery into Target Brain Regions
por: Kobayashi, Kenta, et al.
Publicado: (2017)

Ex Vivo Metrics™, a preclinical tool in new drug development
por: Curtis, C Gerald, et al.
Publicado: (2008)

Commentary: Quo vadis ex vivo lung perfusion—regionalization or centralization?
por: Hoetzenecker, Konrad
Publicado: (2020)

Reclaiming or rebranding marketing: implications beyond digital
por: Ritter, Thomas
Publicado: (2020)

Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion
por: Allan, David S.J., et al.
Publicado: (2021)

Lentiviral Vectors for Ocular Gene Therapy
por: Arsenijevic, Yvan, et al.
Publicado: (2022)

AB115. Effects of target gene expression on ex vivo differentiated mesenchymal stromal cells transfected by lentiviral vector with PDE5 of short hairpin RNA
por: Xiao, Heng-Jun, et al.
Publicado: (2016)

Safe and efficient lentiviral vector integration with HSC-targeted gene therapy
por: Radtke, Stefan, et al.
Publicado: (2023)

Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
por: Deng, Longfei, et al.
Publicado: (2022)

Mapping brain networks in MPS I mice and their restoration following gene therapy
por: Zhu, Wei, et al.
Publicado: (2023)

Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
por: Milani, Michela, et al.
Publicado: (2017)

WFH State‐of‐the‐art paper 2020: In vivo lentiviral vector gene therapy for haemophilia
por: Cantore, Alessio, et al.
Publicado: (2020)

Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
por: Fraldi, Alessandro, et al.
Publicado: (2018)

Development of lentiviral vectors for gene therapy of arthritis
por: Militello, M, et al.
Publicado: (2001)

Cell and Tissue Gene Targeting with Lentiviral Vectors
por: Escors, David, et al.
Publicado: (2012)

In vitro and in vivo gene delivery using a lentiviral vector
por: Gouze-Decaris, E, et al.
Publicado: (2001)

Slow and steady wins the race: Optimizing lentiviral vector production for efficient clinical-scale manufacturing
por: McCarron, Alexandra
Publicado: (2023)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
por: Castellani, Stefano, et al.
Publicado: (2010)

Gene Therapy Applications of Non-Human Lentiviral Vectors
por: Munis, Altar M.
Publicado: (2020)

Target trial emulation: teaching epidemiology and beyond
por: Labrecque, Jeremy A., et al.
Publicado: (2017)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
por: Dai, Wei-Jing, et al.
Publicado: (2016)

Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of Ex Vivo Lentiviral Vector-Transduced Hematopoietic Stem and Progenitor Cells
por: Smith, Miles C., et al.
Publicado: (2022)

How nutrients and natural products act on the brain: Beyond pharmacology
por: de Rus Jacquet, Aurelie, et al.
Publicado: (2023)

The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases
por: Horwitz, David A, et al.
Publicado: (2002)

The feasibility of incorporating Vpx into lentiviral gene therapy vectors
por: McAllery, Samantha A, et al.
Publicado: (2016)

Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
por: Poletti, Valentina, et al.
Publicado: (2021)

Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
por: Horgan, Claire, et al.
Publicado: (2022)

Dosing and Re-Administration of Lentiviral Vector for In Vivo Gene Therapy in Rhesus Monkeys and ADA-Deficient Mice
por: Carbonaro-Sarracino, Denise A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t83tj49rq423a76rnb4lhia4lv